Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • ‘Culture of Success’ – 7 more clinics join Healthia’s fastest growing allied health portfolio
    • News

    ‘Culture of Success’ – 7 more clinics join Healthia’s fastest growing allied health portfolio

    Australia’s fastest growing allied health portfolio has increased further with Healthia (ASX: HLA) acquiring 7 new clinics to grow its national network of healthcare businesses to 293.  The acquisitions include five physiotherapy clinics (Physioworks) and one occupational therapy clinic (Scar Care) in Queensland, and one physiotherapy clinic (Eyre Sports Physiotherapy) in South Australia, expanding Healthia’s

    Read More
    Public
  • I just want (oat) milk that tastes like real milk
    • News

    I just want (oat) milk that tastes like real milk

    When it comes to plant based milks, oat milk reigns supreme (in my opinion at least). However, I often spend far too long standing in the supermarket aisle on my weekly shop deciding which one to buy… Before inevitably picking a selection to sample. Despite what might seem like a near saturated market, alternative milks

    Read More
    Public
  • Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets
    • News

    Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets

    The US Environmental Protection Agency has granted regulatory label approval for the commercialisation of Xtend 21®– an innovative product that has been demonstrated by university studies to enhance long term antimicrobial surface protection. The pathway of Xtend 21® for the US market first commenced in March 2020 when Apiam Animal Health (ASX: AHX) was appointed the exclusive

    Read More
    Public
  • Australian Clinical Labs tips over 1000 collection sites with new acquisition
    • News

    Australian Clinical Labs tips over 1000 collection sites with new acquisition

    Up 23% since their ASX debut in May earlier this year, Australian Clinical Labs (ASX: ACL) are expanding, with the acquisition of Medlab Pathology.  Medlab is a leading private pathology provider comprising two main laboratories and 288 collection sites across both NSW and QLD. The highly complementary acquisition will see ACL’s market share in NSW

    Read More
    Public
  • PlaySide engaged by global gaming company 2K Games in landmark collaboration
    • News

    PlaySide engaged by global gaming company 2K Games in landmark collaboration

    In a landmark deal for Australia’s gaming industry, PlaySide Studios (ASX: PLY) has been engaged for development work by global gaming giant 2K Games, creators of Grand Theft Auto, the NBA 2K series, Borderlands and many more.  2K Games is a label of Take-Two Interactive Software (NASDAQ: TTWO) which has a market cap of USD

    Read More
    Public
  • Credit Clear secures access to $1 billion debt portfolio via Techhub partnership
    • News

    Credit Clear secures access to $1 billion debt portfolio via Techhub partnership

    One of the rarely discussed impacts of the pandemic has been the insane amount of debt drawn upon around the world where global debt has reached record highs of USD $300 trillion. This has presented an opportune time for debt recovery tech company Credit Clear (ASX: CCR) to partner with debt collection company Techub on

    Read More
    Public
  • «
  • ‹
  • 438
  • 439
  • 440
  • 441
  • 442
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.